Minimal-change disease as a paraneoplastic syndrome in a patient with ovarian carcinoma

5Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Minimal-change disease (MCD) is an exceptional paraneoplastic presentation. We are describing the case of an ovarian paraneoplastic nephrotic syndrome. The kidney biopsy was consistent with MCD. Steroids and immunosuppressive therapy were given with no change in the nephroticrange proteinuria. A complete resolution of the nephrotic syndrome was soon observed with improvement of her clinical condition after five cycles of chemotherapy with paclitaxel and carboplatin and tumor-debulking surgery. Ovarian carcinoma paraneoplastic nephrotic syndrome secondary to MCD is an extremely rare event, which is important to recognize since it is responsive to the standard chemotherapy. © The Author 2011.

Cite

CITATION STYLE

APA

González-Fontal, G. R., Restrepo, J. G., & Henao-Martínez, A. F. (2011). Minimal-change disease as a paraneoplastic syndrome in a patient with ovarian carcinoma. NDT Plus, 4(6), 427–429. https://doi.org/10.1093/ndtplus/sfr106

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free